Published in Ann Intern Med on December 01, 1976
Cryptogenic fibrosing alveolitis: clinical features and their influence on survival. Thorax (1980) 3.70
Recommendations for the management of cough in adults. Thorax (2006) 2.41
Production of fibronectin by the human alveolar macrophage: mechanism for the recruitment of fibroblasts to sites of tissue injury in interstitial lung diseases. Proc Natl Acad Sci U S A (1981) 2.34
Idiopathic pulmonary fibrosis. Orphanet J Rare Dis (2008) 2.34
Platelet-derived growth factor in idiopathic pulmonary fibrosis. J Clin Invest (1990) 2.29
Bronchoalveolar lavage in pulmonary fibrosis: comparison of cells obtained with lung biopsy and clinical features. Thorax (1980) 2.28
Mechanisms of pulmonary fibrosis. Spontaneous release of the alveolar macrophage-derived growth factor in the interstitial lung disorders. J Clin Invest (1983) 2.27
Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema. J Clin Invest (1981) 2.20
Mechanisms of neutrophil accumulation in the lungs of patients with idiopathic pulmonary fibrosis. J Clin Invest (1981) 2.10
Human alveolar macrophage-derived chemotactic factor for neutrophils. Stimuli and partial characterization. J Clin Invest (1980) 2.04
Mechanisms of hypoxemia. Lung India (2017) 2.01
Cryptogenic fibrosing alveolitis with preserved lung volumes. Thorax (1997) 1.80
Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis. Thorax (1989) 1.75
Pathogenetic mechanisms in usual interstitial pneumonia/idiopathic pulmonary fibrosis. J Pathol (2003) 1.71
New mechanisms of pulmonary fibrosis. Chest (2009) 1.71
Alveolitis: the key to the interstitial lung disorders. Thorax (1982) 1.71
Alveolar macrophage replication. One mechanism for the expansion of the mononuclear phagocyte population in the chronically inflamed lung. J Clin Invest (1984) 1.68
Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis. J Clin Invest (1987) 1.64
What causes cryptogenic fibrosing alveolitis? A case-control study of environmental exposure to dust. BMJ (1990) 1.61
Small airways in idiopathic pulmonary fibrosis. Comparison of morphologic and physiologic observations. J Clin Invest (1977) 1.61
Structural and functional consequences of alveolar cell recognition by CD8(+) T lymphocytes in experimental lung disease. J Clin Invest (1998) 1.54
Circulating immune complexes in patients with cryptogenic fibrosing alveolitis. Clin Exp Immunol (1979) 1.44
Evidence of type II pneumocyte apoptosis in the pathogenesis of idiopathic pulmonary fibrosis (IFP)/usual interstitial pneumonia (UIP). J Clin Pathol (2001) 1.43
Gamma interferon is the lymphokine and beta interferon the monokine responsible for inhibition of fibroblast collagen production and late but not early fibroblast proliferation. J Exp Med (1985) 1.41
Morphologic-physiologic correlates of the severity of fibrosis and degree of cellularity in idiopathic pulmonary fibrosis. J Clin Invest (1979) 1.41
Molecular and cellular mechanisms of pulmonary fibrosis. Fibrogenesis Tissue Repair (2012) 1.37
The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults. Introduction. Thorax (1999) 1.33
Fibronectin in human bronchopulmonary lavage fluid. Elevation in patients with interstitial lung disease. J Clin Invest (1982) 1.31
Cryptogenic fibrosing alveolitis: prediction of fibrogenic activity from immunohistochemical studies of collagen types in lung biopsy specimens. Thorax (1983) 1.28
Experimental silicosis: morphologic and biochemical abnormalities produced by intratracheal instillation of quartz into guinea pig lungs. Am J Pathol (1980) 1.25
Involvement of Epstein-Barr virus latent membrane protein 1 in disease progression in patients with idiopathic pulmonary fibrosis. Thorax (2000) 1.23
Hyaluronan and type III procollagen peptide concentrations in bronchoalveolar lavage fluid in idiopathic pulmonary fibrosis. Thorax (1989) 1.21
Bleomycin-induced pulmonary fibrosis in hamsters. An alveolar macrophage product increases fibroblast prostaglandin E2 and cyclic adenosine monophosphate and suppresses fibroblast proliferation and collagen production. J Clin Invest (1983) 1.19
Bronchoalveolar lavage. Thorax (1980) 1.18
Concentration, biosynthesis and degradation of collagen in idiopathic pulmonary fibrosis. Thorax (1986) 1.17
Role of tumor necrosis factor-alpha in the spontaneous development of pulmonary fibrosis in viable motheaten mutant mice. Am J Pathol (1997) 1.15
Bleomycin-induced diffuse interstitial pulmonary fibrosis in baboons. J Clin Invest (1978) 1.13
Mice lacking neutrophil elastase are resistant to bleomycin-induced pulmonary fibrosis. Am J Pathol (2007) 1.13
Circulating intercellular adhesion molecule-1 (ICAM-1) antigen in sera of patients with idiopathic pulmonary fibrosis. Clin Exp Immunol (1992) 1.10
Modulation of fibronectin gene expression in human mononuclear phagocytes. J Clin Invest (1987) 1.09
Mycoplasma pneumonia with fulminant evolution into diffuse interstitial fibrosis. Thorax (1980) 1.07
The larger bronchi in cryptogenic fibrosing alveolitis: a morphometric study. Thorax (1982) 1.07
Gamma-interferon inhibits collagen synthesis in vivo in the mouse. J Clin Invest (1987) 1.05
Evaluation of fibronectin gene expression by in situ hybridization. Differential expression of the fibronectin gene among populations of human alveolar macrophages. Am J Pathol (1988) 1.05
Interstitial lung disease: aggressive clinical management versus diagnostic and therapeutic nihilism. West J Med (1982) 1.05
Anchoring fibrils. A new connective tissue structure in fibrotic lung disease. Am J Pathol (1978) 1.05
CD8+ T lymphocytes in lung tissue from patients with idiopathic pulmonary fibrosis. Respir Res (2005) 1.04
Role of connective tissue proteases in the pathogenesis of chronic inflammatory lung disease. Environ Health Perspect (1984) 1.02
Increased blood carboxyhaemoglobin concentrations in inflammatory pulmonary diseases. Thorax (2002) 1.02
Capsaicin induced cough in cryptogenic fibrosing alveolitis. Thorax (2000) 1.02
Genetics and early detection in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2014) 1.01
Pulmonary function testing in idiopathic interstitial pneumonias. Proc Am Thorac Soc (2006) 1.01
The significance of antinuclear and DNA antibodies in cryptogenic fibrosing alveolitis. Thorax (1983) 0.99
Serum type III procollagen peptide concentration in cryptogenic fibrosing alveolitis and its clinical relevance. Thorax (1984) 0.99
Computed tomography based estimates of regional gas and tissue volume of the lung in supine subjects with chronic airflow limitation or fibrosing alveolitis. Thorax (1986) 0.96
Autoantibodies to DNA topoisomerase II in cryptogenic fibrosing alveolitis and connective tissue disease. Clin Exp Immunol (1989) 0.96
Rapidly fatal pulmonary fibrosis: the accelerated variant of interstitial pneumonitis. Thorax (1979) 0.94
Dissecting fibrosis: therapeutic insights from the small-molecule toolbox. Nat Rev Drug Discov (2015) 0.93
Assessment of progression of asbestosis in the sheep model by bronchoalveolar lavage and pulmonary function tests. Thorax (1983) 0.91
Objective cough frequency in Idiopathic Pulmonary Fibrosis. Cough (2010) 0.91
Clinical evaluation of eosinophils in the sputum. J Clin Pathol (1979) 0.91
Idiopathic pulmonary fibrosis : new concepts in pathogenesis and implications for drug therapy. Treat Respir Med (2006) 0.90
Actin-containing cells in human pulmonary fibrosis. Am J Pathol (1981) 0.90
Polyarteritis nodosa associated with idiopathic pulmonary fibrosis: report of two cases. Ann Rheum Dis (1989) 0.89
Effects of inflammation and fibrosis on pulmonary function in diffuse lung fibrosis. Thorax (1990) 0.89
Lymphocyte aggregates persist and accumulate in the lungs of patients with idiopathic pulmonary fibrosis. J Inflamm Res (2013) 0.89
The many uses of bronchoalveolar lavage. Br Med J (Clin Res Ed) (1988) 0.88
Fibroblast chemotactic response elicited by native bronchoalveolar lavage fluid from patients with fibrosing alveolitis. Thorax (1993) 0.88
Oxygen desaturation during sleep and exercise in patients with interstitial lung disease. Thorax (1987) 0.88
Interstitial pulmonary fibrosis with and without associated collagen vascular disease: results of a two year follow up. Thorax (1992) 0.87
Bronchoalveolar lavage. Br Med J (Clin Res Ed) (1982) 0.87
Pulmonary renal syndromes--a review. Yale J Biol Med (1981) 0.85
Soluble intercellular adhesion molecule-1 (ICAM-1) in sera and bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Clin Exp Immunol (1994) 0.85
Using mouse genomics to understand idiopathic interstitial fibrosis. Proc Am Thorac Soc (2007) 0.85
Type I collagen content is increased in lungs of patients with adult respiratory distress syndrome. Thorax (1983) 0.85
Extensive laminin and basement membrane accumulation occurs at the onset of bleomycin-induced rodent pulmonary fibrosis. Am J Pathol (1986) 0.84
Activated alveolar macrophages in subclinical pulmonary inflammation in collagen vascular diseases. Thorax (1988) 0.83
Computed tomography-guided bronchoalveolar lavage in idiopathic pulmonary fibrosis. Thorax (1996) 0.83
Mechanical induction of cough in Idiopathic Pulmonary Fibrosis. Cough (2011) 0.82
Idiopathic pulmonary fibrosis: early detection and referral. Respir Med (2014) 0.82
Immunopathology of the lung: a review. Am J Pathol (1979) 0.81
MicroRNAs as potential targets for progressive pulmonary fibrosis. Front Pharmacol (2015) 0.81
Immunologic concepts relating to the pathogenesis of diffuse interstitial lung diseases (emphasizing granulomatous forms and idiopathic pulmonary fibrosis). Trans Am Clin Climatol Assoc (1980) 0.81
Serum sialyl Lewis X-i antigen in lung adenocarcinoma and idiopathic pulmonary fibrosis. Thorax (2002) 0.78
Nuclear inclusions in alveolar epithelium of patients with fibrotic lung disorders. Am J Pathol (1979) 0.78
Anatomical lung shunting in pulmonary fibrosis. Thorax (1986) 0.78
Decreased pulmonary distensibility in fibrosing alveolitis and its relation to decreased lung volume. Thorax (1989) 0.77
Do we need exercise tests to detect gas exchange impairment in fibrotic idiopathic interstitial pneumonias? Pulm Med (2012) 0.77
Review of pulmonary effects of poly(vinyl chloride) and vinyl chloride exposure. Environ Health Perspect (1981) 0.76
Expression profiling of genes regulated by Fra-1/AP-1 transcription factor during bleomycin-induced pulmonary fibrosis. BMC Genomics (2013) 0.75
Fibrosing alveolitis. Can Med Assoc J (1978) 0.75
A case of fibrosing alveolitis in childhood. J R Soc Med (1991) 0.75
Review of cryptogenic fibrosing alveolitis, including current treatment guidelines. Postgrad Med J (2000) 0.75
What is pulmonary fibrosis? Thorax (1988) 0.75
Progressive dyspnea in a 39-year-old housewife. Can Med Assoc J (1980) 0.75
Treatment of small cell lung carcinoma in association with cryptogenic fibrosing alveolitis. Postgrad Med J (1982) 0.75
Fibrosing alveolitis: extrinsic allergic and cryptogenic. West J Med (1977) 0.75
Clinical, laboratory and radiological findings in pulmonary fibrosis with and without connective tissue disease. Clin Rheumatol (1997) 0.75
Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med (2001) 9.53
Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. JAMA (1996) 7.03
Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J Appl Physiol (1985) (1986) 6.86
Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage. Am J Pathol (1979) 5.94
Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation. Nature (1992) 5.45
Quadricuspid semilunar valve. Am J Cardiol (1973) 5.07
Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am Rev Respir Dis (1990) 4.75
NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations. Ann Intern Med (1982) 4.70
Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med (1977) 4.34
Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage. J Lab Clin Med (1974) 4.31
Analysis of cellular and protein content of broncho-alveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis. J Clin Invest (1977) 4.21
Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. N Engl J Med (1981) 4.02
Primary and secondary neoplasms of the heart. Am J Cardiol (1997) 3.79
Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract (first of two parts). N Engl J Med (1984) 3.73
The congenitally bicuspid aortic valve. A study of 85 autopsy cases. Am J Cardiol (1970) 3.69
Major anomalies of coronary arterial origin seen in adulthood. Am Heart J (1986) 3.57
Normal alveolar epithelial lining fluid contains high levels of glutathione. J Appl Physiol (1985) (1987) 3.51
Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis. J Clin Invest (1985) 3.40
Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J Exp Med (2001) 3.25
Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA. Nat Genet (1993) 3.22
Interstitial lung disease: current concepts of pathogenesis, staging and therapy. Am J Med (1981) 3.08
Sudden death in young athletes. Circulation (1980) 3.05
Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. Lancet (1989) 3.01
Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood (2001) 3.01
Coronary artery imaging with intravascular high-frequency ultrasound. Circulation (1990) 2.97
Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation (2000) 2.94
Activated human monocytes express the c-sis proto-oncogene and release a mediator showing PDGF-like activity. Nature (1986) 2.94
Solitary coronary ostium in the aorta in the absence of other major congenital cardiovascular anomalies. J Am Coll Cardiol (1993) 2.91
Bronchoalveolar lavage. Am Rev Respir Dis (1987) 2.87
The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients. Am J Med (1975) 2.85
Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema. N Engl J Med (1987) 2.81
Lung overexpression of the vascular endothelial growth factor gene induces pulmonary edema. Am J Respir Cell Mol Biol (2000) 2.81
Receptors for immunoglobulin and complement on human alveolar macrophages. J Immunol (1975) 2.74
Spontaneous release of interleukin-2 by lung T lymphocytes in active pulmonary sarcoidosis. N Engl J Med (1983) 2.71
Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy. Circulation (1979) 2.68
Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. Hum Gene Ther (1997) 2.62
Exaggerated spontaneous release of platelet-derived growth factor by alveolar macrophages from patients with idiopathic pulmonary fibrosis. N Engl J Med (1987) 2.62
Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line. J Clin Invest (1992) 2.62
Valve ring abscess in active infective endocarditis. Frequency, location, and clues to clinical diagnosis from the study of 95 necropsy patients. Circulation (1976) 2.58
A preliminary study of aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis. N Engl J Med (1992) 2.57
Acute myocardial infarction and angiographically normal coronary arteries. An unproven combination. Circulation (1976) 2.56
Effectiveness of recombinant desulphatohirudin in reducing restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits. Circulation (1991) 2.52
Alveolar macrophage-derived chemotactic factor: kinetics of in vitro production and partial characterization. J Clin Invest (1980) 2.50
Myocardial ultrastructure in idiopathic hypertrophic subaortic stenosis. A study of operatively excised left ventricular outflow tract muscle in 14 patients. Circulation (1972) 2.49
The autopsy: its decline and a suggestion for its revival. N Engl J Med (1978) 2.49
Evaluation of clinical parameters to predict Mycobacterium tuberculosis in inpatients. Arch Intern Med (2000) 2.46
Gene therapy strategies for tumor antiangiogenesis. J Natl Cancer Inst (1998) 2.44
Molecular basis of alpha-1-antitrypsin deficiency. Am J Med (1988) 2.40
Iron in the heart. Etiology and clinical significance. Am J Med (1971) 2.40
Aortic dissection: anatomy, consequences, and causes. Am Heart J (1981) 2.37
Bronchoalveolar lavage in interstitial lung disease. Ann Intern Med (1978) 2.36
Production of fibronectin by the human alveolar macrophage: mechanism for the recruitment of fibroblasts to sites of tissue injury in interstitial lung diseases. Proc Natl Acad Sci U S A (1981) 2.34
Human alveolar macrophage growth factor for fibroblasts. Regulation and partial characterization. J Clin Invest (1982) 2.33
Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death. J Am Coll Cardiol (2000) 2.33
Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor. J Clin Invest (1992) 2.33
Causes of sudden death in competitive athletes. J Am Coll Cardiol (1986) 2.31
Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract. N Engl J Med (1984) 2.30
Human type III collagen gene expression is coordinately modulated with the type I collagen genes during fibroblast growth. Biochemistry (1986) 2.28
Mechanisms of pulmonary fibrosis. Spontaneous release of the alveolar macrophage-derived growth factor in the interstitial lung disorders. J Clin Invest (1983) 2.27
Fluorescent virions: dynamic tracking of the pathway of adenoviral gene transfer vectors in living cells. Hum Gene Ther (1998) 2.27
Protease-antiprotease imbalance in the lungs of children with cystic fibrosis. Am J Respir Crit Care Med (1994) 2.26
Interleukin-8 gene expression in human bronchial epithelial cells. J Biol Chem (1991) 2.26
Pulmonary host defenses. I. Analysis of protein and lipids in bronchial secretions and antibody responses after vaccination with pseudomonas aeruginosa. J Immunol (1973) 2.25
Mechanism for the inflammatory response in primate lungs. Demonstration and partial characterization of an alveolar macrophage-derived chemotactic factor with preferential activity for polymorphonuclear leukocytes. J Clin Invest (1977) 2.24
Heart in malignant lymphoma (Hodgkin's disease, lymphosarcoma, reticulum cell sarcoma and mycosis fungoides). A study of 196 autopsy cases. Am J Cardiol (1968) 2.23
Rapid, nonradioactive detection of mutations in the human genome by allele-specific amplification. J Lab Clin Med (1989) 2.22
Cigarette smoking induces functional antiprotease deficiency in the lower respiratory tract of humans. Science (1979) 2.20
Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema. J Clin Invest (1981) 2.20
Getting cardiologists interested in lipids. Am J Cardiol (1993) 2.20
Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol (1986) 2.18
Accurate quantification of cells recovered by bronchoalveolar lavage. Am Rev Respir Dis (1984) 2.17
Endomyocardial disease and eosinophilia. A clinical and pathologic spectrum. Am J Med (1969) 2.13
Collagenase in the lower respiratory tract of patients with idiopathic pulmonary fibrosis. N Engl J Med (1979) 2.13
Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity. J Exp Med (1997) 2.12
Expression of the cystic fibrosis transmembrane conductance regulator gene in the respiratory tract of normal individuals and individuals with cystic fibrosis. Proc Natl Acad Sci U S A (1991) 2.12
Intraluminal fibrosis in interstitial lung disorders. Am J Pathol (1986) 2.10
Mechanisms of neutrophil accumulation in the lungs of patients with idiopathic pulmonary fibrosis. J Clin Invest (1981) 2.10
Anomalous origin of either the right or left main coronary artery from the aorta with subsequent coursing between aorta and pulmonary trunk: analysis of 32 necropsy cases. Am J Cardiol (1988) 2.09
The heart in malignant melanoma. A study of 70 autopsy cases. Am J Cardiol (1968) 2.07
Maintenance of granuloma formation in pulmonary sarcoidosis by T lymphocytes within the lung. N Engl J Med (1980) 2.07
Aerosol alpha 1-antitrypsin treatment for cystic fibrosis. Lancet (1991) 2.05
Human alveolar macrophage-derived chemotactic factor for neutrophils. Stimuli and partial characterization. J Clin Invest (1980) 2.04
Specificity of opsonic antibodies to enhance phagocytosis of Pseudomonas aeruginosa by human alveolar macrophages. J Clin Invest (1975) 2.04
Unruptured sinus of Valsalva aneurysm. Am J Cardiol (1975) 2.04
Geometric remodeling is not the principal pathogenetic process in restenosis after balloon angioplasty. Evidence from correlative angiographic-histomorphometric studies of atherosclerotic arteries in rabbits. Circulation (1994) 2.03
Induction of the hair growth phase in postnatal mice by localized transient expression of Sonic hedgehog. J Clin Invest (1999) 2.02
Cardiovascular features of homozygous familial hypercholesterolemia: analysis of 16 patients. Am J Cardiol (1984) 1.99
Dynein- and microtubule-mediated translocation of adenovirus serotype 5 occurs after endosomal lysis. Hum Gene Ther (2000) 1.97
Cigarette smoking and lung destruction. Accumulation of neutrophils in the lungs of cigarette smokers. Am Rev Respir Dis (1983) 1.97
Coronary artery narrowing in coronary heart disease: comparison of cineangiographic and necropsy findings. Ann Intern Med (1979) 1.96
Right-sided valvular infective endocarditis. A clinicopathologic study of twelve necropsy patients. Am J Med (1972) 1.95